SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 17th, 2021 • Molecular Data Inc. • Services-business services, nec • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of September 15, 2021, between Molecular Data Inc., a company incorporated under the laws of the Cayman Islands (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
PRE-FUNDED WARRANT TO PURCHASE CLASS A ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES MOLECULAR DATA INC.Molecular Data Inc. • September 17th, 2021 • Services-business services, nec • New York
THIS PRE-FUNDED WARRANT TO PURCHASE CLASS A ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) until this Warrant is exercised in full (the “Termination Date”), to subscribe for and purchase from Molecular Data Inc., an exempted company formed under the laws of the Cayman Islands (the “Company”), up to ______ Class A Ordinary Shares, par value US $0.00005 (the “Class A Ordinary Share(s)”) (as subject to adjustment hereunder, the “Warrant Shares”)), represented by _____________ American Depositary Share (“ADSs”), each 3 Class A Ordinary Shares representing one ADS, as subject to adjustment hereunder (the “Warrant ADSs”). The purchase price of one Warrant ADS shall be equal to the Exercise Price, as defined
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • September 17th, 2021 • Molecular Data Inc. • Services-business services, nec • New York
Introduction. Subject to the terms and conditions herein (this “Agreement”), Molecular Data Inc. (the “Company”), hereby agrees to sell up to approximately $15,000,000 of securities of the Company directly to accredited investors (each, an “Investor” and collectively, the “Investors”) through Aegis Capital Corp., as placement agent (the “Placement Agent).
PURCHASE WARRANT TO PURCHASE CLASS A ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES MOLECULAR DATA INC.Purchase Warrant • September 17th, 2021 • Molecular Data Inc. • Services-business services, nec • New York
THIS WARRANT TO PURCHASE CLASS A ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES (the “Warrant”) certifies that, for value received, _________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on September 16, 2026 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Molecular Data, Inc., an exempted company formed under the laws of the Cayman Islands (the “Company”), up to _______ Class A Ordinary Shares, par value US $0.00005 (the “Class A Ordinary Share(s)”) (as subject to adjustment hereunder, the “Warrant Shares”), represented by _____________ American Depositary Share (“ADSs”), each 3 Class A Ordinary Shares representing one ADS, as subject to adjustment hereunder (the ADSs issuable hereunder, the “Warrant ADSs”). The purchase price o
